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تعديل يف القطع العظمي لوفور 1 ورأب الذقن لعالج تشوه سين وجهي حاد 
حلالة مصابة أبنيميا البحر املتوسط الكربى
تقرير حالة مع مراجعة أدبية
خمي�س حممد احل�شني، عبدالعزيز عبداهلل باكثري، اأحمد خمي�س الها�شمي، بدر الرواحي، عبداهلل البكري
abstract: β-thalassaemia major is an autosomal recessive form of haemoglobinopathy that is characterised 
by complete lack of production of the β-chains resulting in multiple complications that include severe anaemia, 
failure to thrive and skeletal abnormalities. Facial deformities induced by β-thalassaemia major are rare and are 
very challenging to treat from a surgical point of view. We report a 33-year-old female patient with β-thalassaemia 
major who presented to the Dental & Maxillofacial Surgery Department, Sultan Qaboos University Hospital, 
Muscat, Oman, in 2017 with gross dentofacial skeletal deformity contributing to her psychosocial issues. The 
facial deformity was corrected surgically by excision of the enlarged maxilla, modified Le Fort I osteotomy and 
advancement genioplasty. This case highlights the pre-operative preparation, surgical management, encountered 
complications and treatment outcome within 24 months of follow-up.
Keywords: Beta-Thalassaemia; Thalassaemia Major; Cooley's Anemia; Le Fort Osteotomy; Genioplasty; Dentofacial 
Deformities; Case Report; Oman.
امللخ�ص: اأنيميا البحر املتو�شط  الكربى هي �شكل �شبغي ج�شدي متنحي من اعتالل الهيموغلوبني والذي يتميز بنق�س كامل يف اإنتاج �شال�شل 
بيتا مما يوؤدي اإىل م�شاعفات متعددة ت�شمل فقر الدم ال�شديد، والف�شل يف النمو وت�شوهات الهيكل العظمي. ت�شوهات الوجه الناجمة عن اأنيميا 
البحر املتو�شط الكربى تعترب نادرة وي�شعب عالجها من الناحية اجلراحية. نعر�س هنا حالة مري�شة تبلغ من العمر 33 عاًما م�شابة باأنيميا 
البحر املتو�شط الكربى والتي تقدمت اإىل ق�شم الأ�شنان وجراحة الوجه والفكني مب�شت�شفى جامعة ال�شلطان قابو�س، م�شقط، عمان، يف عام 2017 
مع ت�شوه هيكلي عظمي ج�شيم يف الوجه والأ�شنان والذي اأ�شهم يف م�شاكلها النف�شية والجتماعية. مت ت�شحيح ت�شوه الوجه جراحًيا عن طريق 
ا�شتئ�شال الفك العلوي املت�شخم، ت�شحيح الفك بتعديل يف القطع العظمي لوفور ا1 وراأب الذقن بالتقدمي. ت�شلط هذه احلالة ال�شوء على التح�شري 
قبل اجلراحة والإدارة اجلراحية وامل�شاعفات التي مت مواجهتها ونتائج العالج خالل فرتة 24 �شهًرا من املتابعة.
الكلمات املفتاحية: اأنيميا البحر املتو�شط الكربى ؛ فقر الدم كويل؛ قطع عظم لوفور؛ راأب الذقن؛ ت�شوهات الأ�شنان والوجه؛ تقرير حالة؛ ُعمان.
Modified Le Fort I Osteotomy and Genioplasty for 
Management of Severe Dentofacial Deformity in 
β-Thalassaemia Major
Case report and review of the literature
*Khamis M. Al Hasani,1 Abdulaziz A. Bakathir,2 Ahmed K. Al-Hashmi,3 Badar Al Rawahi,4 Abdullah Albakri1
Sultan Qaboos University Med J, August 2020, Vol. 20, Iss. 3, pp. e362–367, Epub. 5 Oct 20
Submitted 5 Feb 20
Revision Req. 2 Apr 20; Revision Recd. 29 Apr 20
Accepted 21 May 20
myocardial diseases, skeletal abnormalities and other 
complications.4–7
Skeletal changes are common features in 
β-thalassaemia major patients, and in the craniofacial 
region these include bossing of the skull, prominent 
malar eminences giving the typical mongoloid 
facial appearance and maxillary hypertrophy.1,2,5,6 
As a consequence of inadequate erythropoiesis, 
hypertrophy of erythroid marrow tissue especially 
at medullary sites lead to the typical craniofacial 
deformities that are usually seen in poorly transfused 
individuals.3,6,7
β-thalassaemia has been reported as the most common autosomal recessive mutational disorder of haemoglobin (Hb) synthesis, which is 
characterised by reduction or absent synthesis of the 
β-globin chains of the Hb tetramer.1 Cooley and Lee 
reported the first thalassaemia case in 1925 presenting 
with severe anaemia, splenomegaly and characteristic 
skeletal abnormalities.1,2
β-thalassaemia is classified according to the 
mutation in the β-globin genes as thalassaemia 
minor, intermedia and major subtypes.3 Clinically, 
β-thalassaemia major patients present with chronic 
severe anaemia, failure to thrive, hepatosplenomegaly, 
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Surgical management of the facial deformity in 
β-thalassaemia major patients is challenging. Various 
surgical treatment options have been advocated 
particularly for the surgical correction of the enlarged 
maxilla, however, most are published as case reports 
with some controversies on the complexity of these 
procedures.8–10 
We report a rare case of severe dentofacial 
deformity in a β-thalassemia major patient who 
underwent surgical correction with a successful and 
stable outcome.
Case Report
A 33-year-old female patient with β-thalassaemia 
major was referred to the Dental & Maxillofacial 
Surgery Department, Sultan Qaboos University 
Hospital, Muscat, Oman, in 2017 for evaluation and 
management of her dentofacial deformity. The patient’s 
chief complaints were related to her poor aesthetics, 
malocclusion and excessive upper jaw enlargement.
The patient was diagnosed with β-thalassaemia 
major at the age of two years and was also known to 
have diabetes mellitus, coagulopathy and moderate 
liver iron over-load. Moreover, she had no history 
of splenectomy or platelet dysfunction and her 
medical treatment included regular monthly blood 
transfusions, metformin and oral iron-chelating 
agents, which were recently changed to intravenous 
deferoxamine to improve her iron over-load status. 
Clinical examination showed pallor of the skin 
and oral mucosa, prominent left maxilla, incompetent 
lips with excessive tooth show at rest. Intraorally, 
there was an excessive vertical expansion of the left 
maxilla resulting in an occlusal cant. There was also 
malocclusion with dental crowding and a noticeable 
increased overjet [Figure 1].
Radiographic imaging showed poor maxillary 
bone density with obliteration of the maxillary sinuses 
and gross left maxillary bone enlargement especially 
in the premolar and molar regions [Figures 1 and 2]. 
A lateral cephalogram showed severe proclination 
of the upper and lower anterior teeth and moderate 
retrogenia.
The patient requested surgical correction of 
her dentofacial deformity. Surgical options including 
conventional orthodontic-orthognathic treatment, 
modified Le Fort I osteotomy and genioplasty with 
excision of the enlarged maxillary mass were explained 
to the patient. The patient understood the due risks 
and complications. She chose the modified maxillary 
osteotomy and genioplasty without pre-surgical 
orthodontics. 
The patient’s pre-operative investigations showed 
a haemoglobin level of 9 g/dL, deranged coagulation 
with increased activated partial thromboplastin time 
and fibrinogen as well as reduction factor IX and XII 
levels. Pre-operatively, a haematologist was consulted 
and the recommended blood transfusion raised the 
patient’s Hb level to 11.4 g/dL and transfused fresh 
frozen plasma (FFP) was arranged to correct the 
coagulopathy status.
Under nasotracheal intubation and antibiotic 
prophylaxis with second-generation cephalosporin, 
 
Figure 1: Pre-operative clinical photographs and radiographic images of a 33-year-old female patient with β-thalassaemia 
showing (A) frontal and (B) lateral views showing lip incompetence, excessive teeth showing and maxillary enlargement. 
Orthopantogram showing (C) left maxillary enlargement with obliteration of the maxillary sinuses and over-eruption of 
left maxillary teeth. Lateral cephalogram showing (D) severe proclination of the upper and lower anterior teeth, increased 
overjet and moderate retrogenia.
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bilateral full crevicular incisions were performed to 
expose the maxilla, which revealed a lack of bony 
cortex with presence of very loose honeycombed 
medullary bone overlying the expanded maxilla. The 
hypertrophied bone of the left maxilla was excised 
together with extractions of maxillary posterior teeth 
18, 17, 27 and 28. At the extraction sites, bilateral 
vertical osteotomies were performed which were 
linked by bilateral horizontal osteotomies 5 mm above 
the apices of the remaining teeth (modified Le Fort I 
osteotomy without involving the pterygoid plates or 
the nasal floor). An additional horizontal osteotomy 
was performed above the initial horizontal osteotomy 
bilaterally to facilitate maxillary impaction, by 
removing a wedge of bone between the two horizontal 
osteotomies. The maxilla, as a single segmental unit, 
was then mobilised and impacted 6 mm on the right 
side and 4 mm on the left side and was set back by 
4 mm. Fixation was then accomplished using five 
2.0 mm bone plates and screws with good stability. 
Following the closure of the maxillary surgical area, 
a conventional 6 mm advancement genioplasty was 
performed uneventfully [Figure 3]. 
Intra-operatively, persistent oozing from the 
hyperplastic maxilla was encountered throughout 
the procedure, which resulted in dropping of the Hb 
level to 7 g/dL, requiring multiple blood and FFP 
transfusions. The combination of using absorbable 
haemostatic agent (Surgicel®, Ethicon, Hamburg, 
Germany) packing, tranexamic acid, stable maxillary 
fixation and soft tissue closure resulted in good control 
of the intra-operative bleeding. 
Post-operatively, the patient developed moderate 
facial oedema, mild maxillary oozing but had no signs 
of surgical infection. Local measures consisting of 
oral packing and tranexamic acid rinses were utilised 
to control the post-operative ooze. Further post-
operative drop of Hb required an additional two units 
of blood transfusion.
Two weeks post-operatively, the patient’s general 
condition improved with resolution of the facial 
oedema and adequate healing of the surgical sites 
with satisfactory occlusion, acceptable tooth show at 
rest and a good facial profile. At 24 months follow-up, 
the patient was pleased with the surgical outcome and 
clinical assessment revealed satisfactory facial profile 
and stable occlusion with no evidence of significant 
surgical relapse [Figure 4]. 
The patient’s verbal consent was obtained to use 
her clinical images for educational and publication 
purposes; this was documented in the patient’s 
medical file.
 
Figure 3: Intra-operative surgical photographs of a 33-year-old female patient with β-thalassaemia showing the intraoral 
view showing a hypertrophied left maxillary bony mass, excised hypertrophied left maxillary mass and fixation and 
stabilisation of modified Le Fort osteotomy with multiple mini-plates.
 
Figure 2: Pre-operative cone beam computed tomography of the head of a 33-year-old female patient with β-thalassaemia 
showing (A) 3-dimensional reconstruction scan showing extensive left maxillary mass with lack of bony cortex. Coronal 
(B) and axial (C) cuts demonstrating left maxillary medullary expansion with overlapping downward overgrowth of the 
left maxilla and obliteration of the maxillary sinuses.
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Discussion 
β-thalassaemia major, also known as Cooley’s 
anaemia and transfusion-dependent thalassaemia, is a 
hereditary form of severe anaemia that is commonly 
prevalent among natives of the Mediterranean and 
Middle Eastern and Asian countries.3 In recent years, 
the life expectancy of β-thalassaemia major patients 
has improved dramatically as reported in different 
countries, nevertheless, serious disease-related 
complications are still common and pose a direct 
impact on the quality of life and increases patient 
morbidity and mortality.11–13 
β-thalassaemia major patients are well known 
to have skeletal changes, particularly orofacial 
deformity and the prevalence and severity of such 
deformity coincides with the degree of ineffective 
erythropoiesis and extra-medullary haematopoiesis.6,14 
The typical features of the facial deformity manifest 
clinically as frontal bossing, obliteration of the nasal 
sinuses, depression of the nasal bridge, protrusion 
of zygoma and expansion of the maxilla giving rise 
to a chipmunk-like appearance or rodent-like face 
and dental malocclusion.14 The pathogenesis of such 
skeletal changes are related to the hyperplasia and 
hypertrophy of the marrow erythroid under influence 
of the hyperactivity of the red marrow that leads to 
expansion of the medullary cavities and thinning 
of the cortical structures resulting in an overall loss 
of bone density, which is commonly seen in the 
maxilla.6,14,15 The facial changes are more pronounced 
as haematopoiesis continues in the cranium 
compared to other sites in the body. The mandible 
undergoes less changes than the maxilla and usually 
results in a retrognathic facial appearance.6,9,14,16 The 
dentition appears displaced as a consequence of the 
maxillary expansion and accordingly, results in dental 
malocclusion and functional difficulties during eating, 
swallowing and speech.9 
Iron over-load is a common complication in 
β-thalassaemia major patients.1,3,10,17,18 It occurs due 
to the ineffective erythropoiesis and/or transfusion 
iron over-load. Ineffective erythropoiesis promotes 
an increase of the intestinal iron uptake that has an 
influence over iron balance regulation. In addition, 
iron also has the potential to precipitate within the 
parenchyma of the heart and liver and eventually leads 
to haemochromatosis. Growth impairment, cirrhosis, 
hepatosplenomegaly, endocrine and metabolic 
abnormalities and cardiac complications are the main 
sequelae of haemochromatosis.3,10,13,17–19 Oral iron 
chelating agents are widely used in β-thalassaemia 
major patients to prevent iron over-load.1,3,10,17,18 
Evidence suggests that iron chelation therapy can 
arrest the progression of endocrine abnormalities and 
liver and heart complications.18 However, patients’ 
compliance with oral therapy is often reported to be 
poor.17,18,20 In non-compliant patients with evidence 
 
Figure 4: Post-operative (24 months) clinical photographs and radiographic images of a 33-year-old female patient 
with β-thalassaemia showing the (A) frontal and (B) lateral views showing a pleased patient with satisfactory facial 
profile. Intra-oral view showing (C) stable occlusion with symmetrical and harmonised maxillary buccal buttress. 
Orthopantogram showing (D) stable occlusion with plates used for mandibular and maxillary osteotomy procedure and 
(E) a lateral cephalogram showing satisfactory chin position and lateral profile.
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of iron over-load, intravenous deferoxamine is 
indicated with a good outcome despite the high cost 
of treatment.17,18 In the current case, the patient was 
placed on intensive intravenous deferoxamine for 
over a year prior to surgery to correct the iron over-
load status. Despite the improved iron status, the 
existence of coagulopathy and diabetes as previous 
complications of iron over-load were major surgical 
challenges. 
There are a limited number of case reports on 
the surgical correction of β-thalassaemia-induced 
facial deformity.8–10 There are few published reports 
addressing facial deformity in this group which 
included cases of thalassaemia intermedia.3,8,9,16 The 
suggested treatment includes surgical reduction 
of the enlarged maxillary bone and/or surgical jaw 
correction with or without associated orthodontic 
treatment.8–10,16 Re-contouring the enlarged maxillary 
bone was a highly suggested treatment option, 
however, most reports were based on thalassaemia 
intermedia cases.1,5,8 Mortazavi and Khojasteh 
reported performing surgical re-contouring of the 
enlarged maxilla with dental clearance of maxillary 
teeth to facilitate the insertion of dental prosthesis 
thus, correcting the skeletal and dental deformities.8
The most commonly reported surgical form of 
management of the β-thalassaemia-induced facial 
deformity is surgical re-contouring along with either 
segmental osteotomy or a Le Fort I osteotomy.8–10,16,21,22 
Segmental osteotomy is more frequently used for 
vertical and sagittal repositioning of the premaxilla in 
the inter-canine area after extraction of the bilateral 
canines or first premolars to produce a reasonable 
occlusal relationship and facial harmony.8,23 Le Fort I 
osteotomy is less frequently reported in the literature 
compared to segmental osteotomy and purposely used 
for superior and posterior repositioning of the enlarged 
maxilla.8,10,22 In earlier reports, there was a preference 
for carrying out the surgical procedures in two-stages 
rather than a single-stage, owing to the potential 
increased risk of bleeding and surgical complications 
during a single long procedure.8,10,16,21 Currently, 
the tendency is to perform both procedures of re-
contouring and segmental or Le Fort I osteotomies 
jointly.8,16 In the current case, the decision of surgical 
treatment was determined based on the patient’s 
choice, haematological status and the potential 
complications of the treatment. Hence, a single-
stage modified Le Fort I osteotomy (large one-unit 
segmental osteotomy), resection of enlarged maxilla 
and conventional genioplasty were performed. 
The midface is a well-known highly vascularised 
area and in patients presenting with β-thalassaemia-
induced deformity, this region is further characterised 
by expansion and very porous cancellous bone, thus, 
during the surgical procedure, excessive bleeding is 
expected from mucosal and bone tissues.8,10,22 There are 
no guidelines or consensus for optimal peri-operative 
Hb level prior to surgery for β-thalassaemia major 
patients, however, transfusion should be considered 
in patients with low Hb levels.8,10,24 Published work 
has shown that in operated cases of β-thalassaemia-
induced facial deformity between 1969 and 2004, at 
least 2 units of blood were required as a pre-operative 
measure.8,10 Furthermore, blood transfusion was 
also recommended in the intra- and post-operative 
stages depending on the nature of bleeding and the 
Hb levels.4,8–10,16,22,24 Pre-operatively, following an 
assessment by the haematologist, the current patient’s 
Hb level was raised to 11.4  g/dL and FFP was transfused 
to correct the coagulopathy status. Intra-operatively, 
multiple measures were employed to minimise 
bleeding during the maxillary procedure including 
hypotensive anaesthesia, sub-periosteal gingival 
dissection and the application of local measures of 
oxidised regenerated cellulose packing impregnated 
with tranexamic acid. In addition, performing a less 
invasive modified Le Fort I osteotomy instead of the 
conventional Le Fort I osteotomy, which requires 
pterygomaxillary disjuncture plates, also contributed 
in minimising the intra-operative bleeding. Despite 
all these measures, continuous bleeding from the 
porous maxilla was encountered intra-operatively 
and accordingly four units of blood were transfused. 
Bleeding from the surgical site further reduced 
following fixation of the maxilla and soft tissue 
closure. Post-operatively, bleeding from the surgical 
site and haematoma formation are the most commonly 
reported complications that need blood transfusion 
and haematoma evacuation, respectively.8,10 The 
current patient had a drop in Hb level, which required 
the transfusion of a further two units of blood. The 
encountered pre-, intra- and post-operative findings 
and their management are in line with other published 
reports.8–10,16
The facial surgical correction had a positive 
impact on the patient’s social and psychological status 
which is in line with the literature.7,8,10,17,22 A successful 
outcome of the dentofacial deformity correction in 
β-thalassaemia patients is dependent on understanding 
the medical status of the patient, coordinating with 
the haematologist and anaesthesiologist, good 
surgical planning and preventing complications.8 The 
presented case had a satisfactory and stable outcome 
in terms of aesthetics and occlusion at 24 months 
follow-up.
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Conclusion
Maxillary jaw deformity in β-thalassaemia major 
patients is rare and is very challenging surgically. 
Careful case selection, assessment, pre-operative 
planning and surgical management are important 
to avoid complications and to achieve the required 
surgical outcome. 
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